<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; SCM</title>
	<atom:link href="http://www.tapanray.in/tag/scm/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Blockchain: Pharma Keeps An Eye On The Ball</title>
		<link>http://www.tapanray.in/blockchain-pharma-keeps-an-eye-on-the-ball/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=blockchain-pharma-keeps-an-eye-on-the-ball</link>
		<comments>http://www.tapanray.in/blockchain-pharma-keeps-an-eye-on-the-ball/#comments</comments>
		<pubDate>Sun, 21 Jan 2018 23:31:36 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Bitcoin]]></category>
		<category><![CDATA[Blockchain]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[Chief]]></category>
		<category><![CDATA[Clinical]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[Maharashtra]]></category>
		<category><![CDATA[Minister]]></category>
		<category><![CDATA[Officer]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[SCM]]></category>
		<category><![CDATA[substandard]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[trace]]></category>
		<category><![CDATA[Track]]></category>
		<category><![CDATA[Trial]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8772</guid>
		<description><![CDATA[On April 24, 2017, The Wall Street Journal (WSJ) came out with an interesting headline, “Dubai Aims to Be a City Built on Blockchain.” Some may have taken note of it seriously. However, a vast majority of its readers possibly &#8230; <a href="http://www.tapanray.in/blockchain-pharma-keeps-an-eye-on-the-ball/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/blockchain-pharma-keeps-an-eye-on-the-ball/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SCM: Embracing Technology For Patients’ Safety</title>
		<link>http://www.tapanray.in/scm-embracing-technology-for-patients-safety/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=scm-embracing-technology-for-patients-safety</link>
		<comments>http://www.tapanray.in/scm-embracing-technology-for-patients-safety/#comments</comments>
		<pubDate>Sun, 17 Dec 2017 23:40:31 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[CDSCO]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[Combiflam]]></category>
		<category><![CDATA[D-Cold]]></category>
		<category><![CDATA[DGFT]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[DSCSA]]></category>
		<category><![CDATA[embracing]]></category>
		<category><![CDATA[harnessing]]></category>
		<category><![CDATA[identifier]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Leveraging]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[notification]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Product]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Safety]]></category>
		<category><![CDATA[SCM]]></category>
		<category><![CDATA[serialization]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[system]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[trace]]></category>
		<category><![CDATA[Track]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8646</guid>
		<description><![CDATA[Supply Chain Management (SCM) in the pharma industry is generally perceived as a logistic function, just in most other industries, involving the distribution of medicines from manufacturing plants, right up to pharma distributors. Thereafter, it becomes the responsibility of the &#8230; <a href="http://www.tapanray.in/scm-embracing-technology-for-patients-safety/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/scm-embracing-technology-for-patients-safety/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>To avoid “Heparin” like tragedy in future, a robust “supply chain integrity and security” system is of critical importance</title>
		<link>http://www.tapanray.in/to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance</link>
		<comments>http://www.tapanray.in/to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance/#comments</comments>
		<pubDate>Mon, 29 Mar 2010 00:30:14 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[avoid]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[critical]]></category>
		<category><![CDATA[future]]></category>
		<category><![CDATA[Heparin]]></category>
		<category><![CDATA[importance]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[Integrity]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[like]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Robust]]></category>
		<category><![CDATA[SCM]]></category>
		<category><![CDATA[SCS]]></category>
		<category><![CDATA[Security]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[system]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[tragedy]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=448</guid>
		<description><![CDATA[Globally the pharmaceutical industry is going through a metamorphosis. The types of changes that are taking place today globally, perhaps has no precedence.. The key drivers of these changes are mainly the following: 1. A large number of patent expiration &#8230; <a href="http://www.tapanray.in/to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
